[Detection of relapse in ovarian cancer by PET-FDG].
Jiménez Bonilla
J
J
Centro PET Complutense. Madrid.
Moya García
F
F
Zomeño Rodríguez
M
M
Ordovás Oromendía
A
A
Konsvintseva
O
O
Martín Jorge
R
R
Maldonado Suárez
A
A
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018284:Cystadenocarcinoma, Serous / Q000000981:diagnostic imaging / Q000556:secondary*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D010052:Ovariectomy; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013160:Splenic Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary*; D014057:Tomography, X-Ray Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18